DL Divi's Laboratories Stock: price and insider trades · India · SEBI (PIT + SAST)Track the Divi's Laboratories stock price and the full management transaction log of the company, a listed equity based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). The latest transaction was disclosed on 8 September 2026 (Disposal). Among the most active insiders: K. Sridevi. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 September 2026
All Executives15 Thresholds0 Prospectus0 Other0
Declarations 15 total
● Immediate Relative · Executives · 8 Sept 2026
200 shares @ ₹9,280.00 Equity SEBI:f5d70951f7395ddf9224eadac7e83fdb1bacbb02 ● Immediate Relative · Executives · 31 Aug 2026
200 shares @ ₹9,250.00 34.8% of flow Equity SEBI:eb0f9c488093004fcca6d42dcd5fc534a43bfda0 ● Immediate Relative · Executives · 28 Aug 2026
200 shares @ ₹8,850.00 50.8% of flow Equity SEBI:deade9f9130ab8e457bcb7d8f9257413cb322a02 ▲ Designated Person · Executives · 21 Aug 2026
1,575 shares @ ₹8,560.00 100.0% of flow Equity SEBI:c4ee68599ba315df6d3ba5d8b7f752549272fdaa Canonical exit: 19 Nov 2026 (T+90) ● Promoter Group · Executives · 13 Aug 2026
20,000 shares @ ₹8,416.10 100.0% of flow Equity SEBI:505d1b74d7d0ecf6ba76f620ae270fe0c24d355e ● Immediate Relative · Executives · 12 Aug 2026
200 shares @ ₹8,475.00 100.0% of flow Equity SEBI:73f3ee22480bc2628fa3bcefc1d5047f36519308 ▲ Immediate Relative · Executives · 10 Aug 2026
351 shares @ ₹6,698.60 100.0% of flow Equity SEBI:568ed03ab7b5945e4c5aa634092e2911e95b617a Canonical exit: 8 Nov 2026 (T+90) ▲ Immediate Relative · Executives · 1 Jul 2026
351 shares @ ₹6,698.60 100.0% of flow Equity Shares SEBI:799d1ed08a310aa71ea1f3857cb5df36f838e164 Canonical exit: 29 Sept 2026 (T+90) ● Designated Person · Executives · 1 Jul 2026
4,200 shares @ ₹6,550.00 21.1% of flow Equity SEBI:457626144e2d7dd9083c589fd4e0974cf8f634d3 ● Immediate Relative · Executives · 25 Jun 2026
300 shares @ ₹6,743.00 100.0% of flow Equity Shares SEBI:62d5b893423812ce36b738a3607ff0190ca92784 ▲ Immediate Relative · Executives · 25 Jun 2026
300 shares @ ₹6,743.00 100.0% of flow Equity Shares SEBI:1353f5701ad825736fc7696269b3ca2d5011a3ea Canonical exit: 23 Sept 2026 (T+90) ● Designated Person · Executives · 6 Jun 2026
15,800 shares @ ₹6,687.30 100.0% of flow Equity Shares SEBI:d9a9175d87be3fdde9abf3fd82a965ccad2f2d61 ▲ Immediate Relative · Executives · 3 Jun 2026
400 shares @ ₹6,681.90 100.0% of flow Equity Shares SEBI:e3577b9ced953696ee39ae7afda03bc7a8f307f4 Canonical exit: 1 Sept 2026 (T+90) ▲ Immediate Relative · Executives · 30 May 2026
1,000 shares @ ₹6,753.00 100.0% of flow Equity Shares SEBI:a88bc60229002824d6575b97c8130e9f8485ec37 Canonical exit: 28 Aug 2026 (T+90) ● Designated Person · Executives · 30 May 2026
1,000 shares @ ₹6,753.00 100.0% of flow Equity Shares SEBI:4291e674bfaaeb039d525425ed2059af75dc1320 关于 Divi's Laboratories Divi's Laboratories 是一家印度制药公司，专门从事医药化学品和活性药物成分的制造。该公司在孟买证券交易所上市。